drugset / Trial / NCT03102489
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers.
Timeline
- Start
- 2017-02-22
- Primary completion
- 2017-06-21
- Completion
- 2017-09-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BP101 | Unknown | — | Intranasal |